The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 118-122

  Farooq, Shukkur M ^a   Elkhatib, Walid F ^b,c,d   Ashour, Hossam M ^a,e  

^a WAYNE STATE UNIVERSITY   (United States)

^b Ain Shams University   (Egypt)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d HAMPTON UNIVERSITY   (United States)

^e CAIRO UNIVERSITY   (Egypt)

Author keywords

ACAID; CD8+ Tregs; DTH assay; EAE; Immune privilege; LAT assay; MBP; MOG; Multiple sclerosis; Peripheral tolerance; Regulatory T cells

Indexed keywords

ENCEPHALITOGENIC PROTEIN; MYELIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANTERIOR EYE CHAMBER; ANTERIOR EYE CHAMBER ASSOCIATED IMMUNE DEVIATION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EXTERNAL EAR; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; OPTIC NEURITIS; REGULATORY T LYMPHOCYTE; SPLEEN CELL; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; MYELIN SHEATH;

ADOPTIVE TRANSFER; ANIMALS; ANTERIOR CHAMBER; DISEASE MODELS, ANIMAL; IMMUNE TOLERANCE; MICE; MICE, INBRED C57BL; MYELIN BASIC PROTEIN; MYELIN SHEATH; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; T-LYMPHOCYTES, REGULATORY;

EID: 84908609376     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.06.010     Document Type: Article

References (25)

1. Ashour H.M., Niederkorn J.Y. Gammadelta T cells promote anterior chamber-associated immune deviation and immune privilege through their production of IL-10. J. Immunol. 2006, 177:8331-8337.
2. Ashour H.M., Niederkorn J.Y. Peripheral tolerance via the anterior chamber of the eye: role of B cells in MHC class I and II antigen presentation. J. Immunol. 2006, 176:5950-5957.
3. Ashour H.M., Seif T.M. The role of B cells in the induction of peripheral T cell tolerance. J. Leukoc. Biol. 2007, 82:1033-1039.
4. Cone R.E., Chattopadhyay S., O'Rourke J. Control of delayed-type hypersensitivity by ocular- induced CD8+ regulatory T cells. Chem. Immunol. Allergy 2008, 94:138-149.
5. Cone R.E., Pais R. Anterior chamber-associated immune deviation (ACAID): an acute response to ocular insult protects from future immune-mediated damage?. Ophthalmol. Eye Dis. 2009, 1:33-40.
6. Dahal L.N., Hall L.S., Barker R.N., Ward F.J. Indoleamine 2,3 dioxygenase contributes to transferable tolerance in rat red blood cell inducible model of experimental autoimmune haemolytic anaemia. Clin. Exp. Immunol. 2013, 173:58-66.
7. Farooq S.M., Ashour H.M. Type II collagen induces peripheral tolerance in BALB/c mice via the generation of CD8+ T regulatory cells. PLoS One 2012, 7:e48635.
8. Farooq S.M., Ashour H.M. Eye-mediated induction of specific immune tolerance to encephalitogenic antigens. CNS Neurosci. Ther. 2013, 19:503-510.
9. Farooq S.M., Ashour H.M. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens. Brain Behav. Immun. 2014, 35:64-69.
10. Gu Z., Chhabra A.Y., Alard P., Warner D.R., Kosiewicz M.M. FcgammaRI is required for TGFbeta2-treated macrophage-induced tolerance. Immunobiology 2013, 218:1200-1206.
11. Hsu S.M., Mathew R., Taylor A.W., Stein-Streilein J. Ex vivo tolerogenic F4/80 antigen presenting cells (APC) induce efferent CD8 Treg cell dependent suppression of experimental autoimmune uveitis. Clin. Exp. Immunol. 2013.
12. Huarte E., Rynda-Apple A., Riccardi C., Skyberg J.A., Golden S., Rollins M.F., Ramstead A.G., Jackiw L.O., Maddaloni M., Pascual D.W. Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. J. Autoimmun. 2011, 37:328-341.
13. Jagessar S.A., Heijmans N., Blezer E.L., Bauer J., Blokhuis J.H., Wubben J.A., Drijfhout J.W., van den Elsen P.J., Laman J.D., Hart B.A. Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant. Eur. J. Immunol. 2012, 42:217-227.
14. Kezuka T., Sakai J.I., Usui N., Streilein J.W., Usui M. Evidence for antigen-specific immune deviation in patients with acute retinal necrosis. 2001. Ocul. Immunol. Inflamm. 2007, 15:241-248.
15. Konya C., Goronzy J.J., Weyand C.M. Treating autoimmune disease by targeting CD8(+) T suppressor cells. Expert Opin. Biol. Ther. 2009, 9:951-965.
16. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
17. Milovanovic M., Volarevic V., Ljujic B., Radosavljevic G., Jovanovic I., Arsenijevic N., Lukic M.L. Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotype. PLoS One 2012, 7:e45225.
18. Niederkorn J.Y. The induction of anterior chamber-associated immune deviation. Chem. Immunol. Allergy 2007, 92:27-35.
19. Niederkorn J.Y. Regulatory T cells and the eye. Chem. Immunol. Allergy 2007, 92:131-139.
20. Paunicka K., Chen P.W., Niederkorn J.Y. Role of IFN-gamma in the establishment of anterior chamber-associated immune deviation (ACAID)-induced CD8+ T regulatory cells. J. Leukoc. Biol. 2012, 91:475-483.
21. Skelsey M.E., Mayhew E., Niederkorn J.Y. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation. Invest. Ophthalmol. Vis. Sci. 2003, 44:5242-5251.
22. Streilein J.W. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 2003, 3:879-889.
23. Taylor A.W. Ocular immune privilege. Eye (Lond) 2009, 23:1885-1889.
24. Wilbanks G.A., Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 1990, 71:383-389.
25. Zheng H., Zhang H., Liu F., Qi Y., Jiang H. T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis. Immunol. Lett. 2013, 157:38-44.